Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Fortis Healthcare Q3...

    Fortis Healthcare Q3 net profit at Rs 453.29 crores

    Written by supriya kashyap kashyap Published On 2017-02-15T11:13:52+05:30  |  Updated On 15 Feb 2017 11:13 AM IST

    New Delhi : Fortis Healthcare reported a net profit of Rs 453.29 crore for the third quarter ended December 31, 2016-17.


    The company had reported net loss of Rs 29.16 crore in the same quarter of last fiscal.


    Its consolidated total income from operations stood at Rs 1,133.38 crore for the third quarter of current fiscal, compared with Rs 1,026.52 crore in the year-ago period, Fortis said in a BSE filing.


    Fortis Healthcare said results are are not comparable, as the consolidated result includes financial results of FHTL which it had invested in last year.


    It has completed acquisition of 51 per cent economic interest in Fortis Hospotel Ltd (FHTL) from RHT.


    Fortis Healthcare CEO Bhavdeep Singh said: “Like all other healthcare players, we have been impacted by demonetisation, however we have still continued to grow on most parameters in comparison to last year and the trailing quarter”.


    During the quarter, revenue of its hospital Business stood at Rs 917.2 crore while revenue from its diagnostics business was at Rs 188 crore.


    Fortis Healthcare stock closed 5.25 per cent up at Rs 195.60 on BSE.

    AcquisitionFHTLFortisFortis HealthcareHealthcareMr Bhavdeep Singh
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok